Abstract: A method of treating an individual having a disease selected from communication disorder, abnormal motor ability, cognitive disorder, mental disorder, sensory disturbance, autism spectrum disorder, and pervasive developmental disorder is disclosed. The method includes administering L-serine or a pharmaceutically acceptable salt thereof or a pharmaceutical composition containing L-serine or a pharmaceutically acceptable salt thereof to an individual having the disease.
Abstract: The present invention relates to a novel compound which can function as a molecular glue, or an enantiomeric compound thereof, and a method for preparing these compounds and uses thereof.
Abstract: The present invention relates to use of a novel compound for prevention or treatment of brain cancer, where the novel compound may function as a molecular gluc.
Type:
Application
Filed:
October 15, 2024
Publication date:
April 17, 2025
Applicants:
ASTROGEN, INC., KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
Inventors:
Su-Kyeong Hwang, Hyung Chul Ryu, Hae-June Lee, Soo-Ho Lee
Abstract: A liquid preparation and a method for preparing the liquid preparation are disclosed. The liquid preparation contains a high-concentration L-serine or a pharmaceutically acceptable salt thereof, and shows an excellent stability and safety. The liquid preparation exhibits excellent pharmacological effects and is suitable for preventing or treating a central nervous system disease.
© 2025 Justia
